Mills Andrew J.

SEC Form 4 insider trading activity

Mills Andrew J. has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Dec 22, 2025.

On the most recent filing, Mills Andrew J. is listed as Director at Medline Inc. Inside the rolling window, Mills Andrew J. reported 1 open-market purchase totaling $75.0M in MDLN and no open-market sales.

Companies traded

Other insiders at MDLN

Insider Buying

$75.0M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
MDLNPurchase$75.0MDec 22SEC ↗
Showing 1–1 of 1
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Mills Andrew J. made?

Mills Andrew J. has filed 1 SEC Form 4 filing (2 transaction rows) across 1 company since 2025.

Which companies does Mills Andrew J. trade?

Mills Andrew J. has filed SEC Form 4 disclosures for 1 company, including MDLN.

When was Mills Andrew J.'s most recent SEC Form 4 filing?

Mills Andrew J.'s most recent SEC Form 4 filing on Tracefour is dated Dec 22, 2025.

What is Mills Andrew J.'s total buy and sell value in the current window?

Inside the rolling retention window, Mills Andrew J. bought $75.0M and sold $0 based on SEC Form 4 filings.

What was Mills Andrew J.'s largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 2,586,206 MDLN shares on 2025-12-18, worth $75.0M, per SEC Form 4 filings.